Richard A Alm Selected Research

Ceftaroline

10/2017

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Alm Research Topics

Disease

6	Infections 01/2022 - 01/2015
4	Gonorrhea 01/2016 - 09/2014
1	Pneumonia (Pneumonitis) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Urethritis 01/2016
1	Staphylococcal Infections 07/2015
1	Communicable Diseases (Infectious Diseases) 01/2015

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
4	zoliflodacinIBA 01/2016 - 09/2014
2	VaccinesIBA 01/2022 - 12/2020
1	EpitopesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Ceftaroline FDA Link 10/2017
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2015
1	avibactamIBA 01/2015
1	LactamsIBA 01/2015
1	A-Form DNA (A-DNA)IBA 09/2014

Therapy/Procedure

1	Therapeutics 07/2015